Skip Navigation

Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer COBRA

Brief Summary

Type:
Colon

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT04068103

Study #:
STUDY00145364

Start Date:
Apr 27, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04068103

View Complete Trial Details & Eligibility at ClinicalTrials.gov